سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

CRISPR/Cas mediated genome editing in medicinal plants

Publish Year: 1399
Type: Conference paper
Language: English
View: 412

This Paper With 11 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

MPSA11_049

Index date: 13 April 2021

CRISPR/Cas mediated genome editing in medicinal plants abstract

The safe application of the organic materials leads to more popularity of plant-derived medicines in the recent years. For a long time, classical biotechnology techniques have been exploited in order to obtain a multitude of beneficial traits like, from unraveling the entire metabolic pathwayto increased metabolite and nutrient production, etc. However, conventional genetic engineering methods are not suitable for adding large-concerted changes into a plant, because the random insertion of DNA construct into one or more loci in one or more chromosomes can lead toundesirable effects. The CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system was first identified in bacteria and archaea and candegrade exogenous substrates. Therefore, CRISPR/Cas is considered a revolutionary technology in plant biology. Here, we introduce the mechanism of the CRISPR/Cas in particular CRISPR/Cas9, update its recent advances in various applications in plants, and discuss its future prospects to provide an argument for its use in the study of medicinal plants.

CRISPR/Cas mediated genome editing in medicinal plants Keywords:

CRISPR/Cas mediated genome editing in medicinal plants authors

Rahim Ghezzi

Master student in plant genetics and breeding

Leila Nejad Sadeghi

Assistant Professor, Department of Plant Production Engineering and Genetics, Faculty of Agriculture, Shahid Chamran University of Ahvaz.